Zhitong Finance App News, Rongchang Biotech (09995.HK) announced that on November 9, 2026 (after the transaction period), the company signed a license agreement with the licensor Yantai Rongchang Pharmaceutical Co., Ltd. Based on this, the licensor agreed to grant the company an exclusive license to develop, manufacture, commercialize and otherwise use licensed compounds and licensed products worldwide.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Rongchang Biotech (09995.HK) announced that on November 9, 2026 (after the transaction period), the company signed a license agreement with the licensor Yantai Rongchang Pharmaceutical Co., Ltd. Based on this, the licensor agreed to grant the company an exclusive license to develop, manufacture, commercialize and otherwise use licensed compounds and licensed products worldwide.